Similar articles

• [Interferon-1 beta in the treatment of multiple sclerosis].

  [No authors listed] [No authors listed] Nervenarzt. 1995 Sep;66(9 Suppl Interferon):1-16. Nervenarzt. 1995. PMID: 9131093 German. No abstract available.
• Interferon beta treatment of multiple sclerosis.

  Lubic LG. Lubic LG. Neurology. 1994 Jan;44(1):186; author reply 188-90. doi: 10.1212/wnl.44.1.186-b. Neurology. 1994. PMID: 8290069 No abstract available.
• Interferon beta treatment of multiple sclerosis.

  Deming QB. Deming QB. Neurology. 1994 Jan;44(1):186; author reply 188-90. doi: 10.1212/wnl.44.1.186-a. Neurology. 1994. PMID: 8290068 No abstract available.
• Mechanisms of action of interferon-beta in multiple sclerosis.

  Arnason BG, Dayal A, Qu ZX, Jensen MA, Genç K, Reder AT. Arnason BG, et al. Springer Semin Immunopathol. 1996;18(1):125-48. doi: 10.1007/BF00792613. Springer Semin Immunopathol. 1996. PMID: 8984676 Review. No abstract available.
• [Pathogenetic basis for using interferon-beta preparations in treating multiple sclerosis].

  Cheknev SB. Cheknev SB. Vestn Ross Akad Med Nauk. 2001;(12):45-8. Vestn Ross Akad Med Nauk. 2001. PMID: 11845782 Review. Russian. No abstract available.